Foghorn Therapeutics Statements
FH
Data from Foghorn Therapeutics`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2024
Next reporting period:
29 Dec, 2024
Report frequency:
Quarterly
Earnings release date:
04 Nov, 2024
Expected release date:
—
Foghorn Therapeutics Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
7.808
13.4 %
100
—
0
—
—
0
24.689
316.2
6.971
89.3
31.66
1.7 %
405.5
-23.852
1.6 %
-305.5
3.495
44.8
1.235
15.8
-19.122
16.8 %
-244.9
—
0
-19.122
16.8 %
-244.9
-0.305
62.603
6.888
36.4 %
100
—
0
—
—
0
23.797
345.5
7.325
106.3
31.122
-6.4 %
451.8
-24.234
14 %
-351.8
2.87
41.7
0.783
11.4
-22.979
8.1 %
-333.6
—
0
-22.979
8.1 %
-333.6
-0.446
51.58
5.05
-12.5 %
100
—
0
—
—
0
25.534
505.6
7.71
152.7
33.244
6.5 %
658.3
-28.194
-10.7 %
-558.3
2.439
48.3
0.739
14.6
-25.016
-13.1 %
-495.4
—
0
-25.016
-3.8 %
-495.4
-0.59
42.429
5.769
-67 %
100
—
0
—
—
0
24.205
419.6
7.022
121.7
31.227
-9.6 %
541.3
-25.458
-49.1 %
-441.3
2.66
46.1
0.678
11.8
-22.12
-62.5 %
-383.4
1.986
34.4
-24.106
-68 %
-417.9
-0.571
42.233
17.48
212.1 %
100
—
0
—
—
0
26.25
150.2
8.31
47.5
34.56
-8.2 %
197.7
-17.08
46.7 %
-97.7
2.75
15.7
0.72
4.1
-13.61
52.3 %
-77.9
0.74
4.2
-14.35
51.3 %
-82.09
-0.34
42.03
5.6
5.5 %
100
—
0
—
—
0
29.25
522.3
8.4
150
37.65
-2.5 %
672.3
-32.05
3.8 %
-572.3
2.79
49.8
0.71
12.7
-28.55
4.6 %
-509.8
0.94
16.8
-29.49
3.3 %
-526.6
-0.71
41.83
5.31
27 %
100
—
0
—
—
0
29.99
564.8
8.64
162.7
38.63
7.1 %
727.5
-33.32
-4.5 %
-627.5
2.67
50.3
0.72
13.6
-29.93
-3.6 %
-563.7
0.56
10.5
-30.49
-5.5 %
-574.2
-0.73
41.81
4.18
-37 %
100
—
0
—
—
0
28.21
674.9
7.86
188
36.07
3.4 %
862.9
-31.89
-12.8 %
-762.9
5.68
135.9
-2.68
-64.1
-28.89
-12.1 %
-691.1
—
0
-28.89
-12.1 %
-691.1
-0.69
41.8
6.63
47.7 %
100
—
0
—
—
0
26.93
406.2
7.97
120.2
34.89
3.6 %
526.2
-28.26
3.2 %
-426.2
—
0
2.49
37.6
-25.77
5.6 %
-388.7
—
0
-25.77
5.6 %
-388.7
-0.62
41.67
4.49
14.5 %
100
—
0
—
—
0
25.97
578.4
7.7
171.5
33.68
6.2 %
750.1
-29.19
-5 %
-650.1
—
0
1.88
41.9
-27.31
-1.5 %
-608.2
—
0
-27.31
-1.5 %
-608.2
-0.66
41.52
3.92
452.1 %
100
—
0
—
—
0
24.51
625.3
7.22
184.2
31.72
10.1 %
809.2
-27.8
1 %
-709.2
—
0
0.89
22.7
-26.91
7.7 %
-686.5
—
0
-26.91
7.7 %
-686.5
-0.65
41.37
0.71
1675 %
100
—
0
—
—
0
22.46
3163.4
6.33
891.5
28.8
9.5 %
4056.3
-28.09
-7 %
-3956.3
-0.43
-60.6
0.6
84.5
-29.14
-11.7 %
-4104.2
—
0
-29.14
-11.7 %
-4104.2
-0.77
38.05
0.04
-85.7 %
100
—
0
—
—
0
20.49
51225
5.81
14525
26.3
11.7 %
65750
-26.26
-12.9 %
-65650
-0.5
-1250
0.68
1700
-26.08
-12.9 %
-65200
—
0
-26.08
-12.9 %
-65200
-0.71
36.97
0.28
-3.4 %
100
—
0
—
—
0
18.64
6657.1
4.9
1750
23.54
0.5 %
8407.1
-23.26
-0.6 %
-8307.1
-0.5
-178.6
0.65
232.1
-23.11
-0.5 %
-8253.6
—
0
-23.11
-0.5 %
-8253.6
-0.63
36.85
0.29
16 %
100
—
0
—
—
0
18.73
6458.6
4.69
1617.2
23.42
11.4 %
8075.9
-23.13
-11.3 %
-7975.9
-0.49
-169
0.63
217.2
-22.99
-10.7 %
-7927.6
—
0
-22.99
-10.7 %
-7927.6
-0.62
36.82
0.25
38.9 %
100
—
0
—
—
0
16.47
6588
4.56
1824
21.03
12.6 %
8412
-20.78
-12.4 %
-8312
-0.32
-128
0.56
224
-20.76
-13 %
-8304
—
0
-20.76
-13 %
-8304
-0.18
114.53
0.18
—
100
—
0
—
—
0
16.11
8950
2.56
1422.2
18.67
20.1 %
10372.2
-18.49
-19 %
-10272.2
-0.2
-111.1
0.32
177.8
-18.37
-16.9 %
-10205.6
—
0
-18.37
-16.9 %
-10205.6
-1.69
10.88
—
—
100
—
0
—
—
0
13.63
0
1.91
0
15.54
13.3 %
0
-15.54
-13.3 %
0
-0.2
0
0.01
0
-15.72
-12.7 %
0
—
0
-15.72
-12.7 %
0
-0.94
16.72
—
—
100
—
0
—
—
0
11.5
0
2.22
0
13.72
—
0
-13.72
—
0
-0.26
0
0.03
0
-13.95
—
0
—
0
-13.95
—
0
-2.71
5.15